Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen
In This Article:
Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the eyes to swell.
Oops, something went wrong
Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the eyes to swell.